Business Wire

NIELSENIQ

9.11.2021 07:03:09 CET | Business Wire | Press release

Share
Brand Extensions Dominate FMCG Innovation in Europe According to NielsenIQ BASES Annual Breakthrough Innovations Report

NielsenIQ BASES is delighted to announce today the launch of its 2021 annual Breakthrough Innovation Report which awards the most successful consumer packaged goods product launches.

The report, which celebrates its 10th anniversary this year, has unveiled the leading innovations of the FMCG world that have made the biggest impact. The brands that made the list reflect a wide range of products and approaches that succeeded in making meaningful connections with consumers, an impressive feat within an increasingly crowded marketplace.

Of the 98 European winners named in the report over the last decade, over 90% percent are still in the market today. When you compare this figure to the regularly used statistic of 90% of new launches failing to survive beyond two years, this demonstrates that NielsenIQ BASES has got its finger on the pulse when it comes to identifying the winning formula for new product launches.

This year's 25 European cross-category winners include representation across multiple markets including UK, France, Germany, Italy, Norway, Russia, Poland, Spain, Switzerland and the Netherlands. This year, these products were overwhelmingly dominated by line extensions, with nearly all of the winners (96%) coming from existing brands. Among the factors defining their success, the winners saw an 86% average value sales increase from Year 1 to Year 2. This is all the more impressive when you consider typically more than half of new products decline in their second year in market.

Celine Grena, European BASES leader, comments: “It is worth noting that when you go back to the first report launched 10 years ago, trends such as ‘shopping locally’, sustainability and convenience were the ‘ones to watch’. While these trends still exist, a number of these are gradually crystallising into the standout theme of mindful living. In fact, over half of the winners this year have at least one mindful living claim, versus only about one quarter in 2019.”

Findings also show that demand for environmentally conscious products is growing and able to drive premiumisation. Consumers are looking for products that use natural ingredients and more sustainable formulations. And whilst it does not have to be the core of the proposition for some brands, waste reduction or a more sustainable production cycle are key trends within the winners.

Alcoholic beverages find success through attracting category buyers to their brand for the first time or opening up new consumption occasions for the brand. In other beverages and food, the focus is on ingredients with added health benefits to support the mind and body. This trend is leading to consumers actively look for low-sugar, -salt, -carb, - calorie and -fat when buying products. This trend is not confined to humans, our beloved pets are also getting products that tap into this demand with ‘free-from’ credentials.

Transparency is another important factor across categories, with clean (64%), locally grown (52%) and ethically sourced (39%) ingredients the top claims that would most impact brand trust. Consumers want to know what they are consuming, where it is coming from and how it impacts their health, so brands will need to put more emphasis on transparency to achieve sales success in the future.

Grena, continues: “Through this year’s winners, we can see that while health and wellness remains an important area of focus, sustainability is increasing in importance within the European market amid growing concerns about climate change. As this trend gathers pace manufacturers will need to respond to this rising social issue through innovative packaging design, and raising awareness of environmentally conscious credentials, to drive impact for new product launches. Premiumisation is another key area we’re seeing develop, both from a packaging and product performance perspectives, with many consumers willing to pay more for these benefits.”

European Winners (listed in alphabetical order):

  • Aspi Gola (Italy)
  • Birds Eye Green Cuisine (UK)
  • Birra Messina Cristalli Di Sale (Italy)
  • Butcher’s Tripe Loaf (UK)
  • Cadbury Darkmilk (UK)
  • Costa Coffee Ready-to-Drink (UK)
  • Febreze Bathroom Air Freshener (UK)
  • Finish Quantum Ultimate (UK & Germany)
  • Hansa Mango IPA (Norway)
  • Hanuta Riegel (Germany)
  • Innocent Plus (UK & France)
  • J.J Whitley – Artisanal Russian Vodka (UK)
  • Leffe d'Été (France)
  • Magnum Vegan (UK & Germany)
  • Martini Fiero (Russia)
  • Pampers Harmonie (France)
  • Persil 4-in-1 discs (Germany)
  • Pringles Rice Fusion (UK)
  • Rimmel Lasting Radiance (UK)
  • Scholl Dry Skin Foot Mask (Germany)
  • Sensodyne Sensitivity & Gum (UK)
  • Somersby Mango i Limonka (Poland)
  • Starbucks for Nespresso (UK, France, Switzerland, Netherlands and Spain)
  • This Isn’t (UK)
  • Whiskas Pure Delight (UK)

ENDS

For further information, please contact Publicasity at NielsenIQ@publicasity.co.uk

About NielsenIQ BASES Breakthrough Innovation

This year’s Breakthrough Innovation process reviewed over 50,000 product launches. The brands that made the 2021 list reflect a wide range of products and approaches that succeeded in making meaningful connections with consumers, an impressive feat within an increasingly crowded marketplace. Beyond BASES requirements for products that reflect strong, distinct qualities such as mass potential, longevity, brand incrementality, category distinction or appeal toward a specific consumer target, this year’s list brings the continued evolution of the success criteria, which includes all six of NielsenIQ BASES’ activation profiles.

About NielsenIQ

NielsenIQ is the leader in providing the most complete, unbiased view of consumer behavior, globally. Powered by a groundbreaking consumer data platform and fueled by rich analytic capabilities, NielsenIQ enables bold, confident decision-making for the world’s leading consumer goods companies and retailers.

Using comprehensive data sets and measuring all transactions equally, NielsenIQ gives clients a forward-looking view into consumer behavior in order to optimize performance across all retail platforms. Our open philosophy on data integration enables the most influential consumer data sets on the planet. NielsenIQ delivers the complete truth.

NielsenIQ, an Advent International portfolio company, has operations in nearly 100 markets, covering more than 90% of the world’s population. For more information, visit NielsenIQ.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

PPMI and Alipay+ Expand QR Ph for Cross-Border Commerce, Connecting Filipino Businesses with Global Consumers1.9.2026 09:25:00 CEST | Press release

Partnership significantly expands cross-border connectivity, supporting Philippines’ digitalisation ambitions and opening new opportunities for 2.5M local merchants and SMEsAlipay+ connects with 10+ national payment schemes across Asia, Middle East and Latin America The Philippine Payments Management, Inc. (PPMI) and Ant International's unified wallet gateway, Alipay+, have officially enabled Alipay+ on QR Ph, seamlessly connecting the nation's digital payments ecosystem with global commerce. This milestone is in alignment with and supports the Bangko Sentral ng Pilipinas' (BSP) digital payments transformation goals. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901759507/en/ (L-R) Danny Chung, General Manager of Alipay+ Global Growth Center, Ant International; Carmelita “Melit” Araneta, General Manager of Philippine Payments Management Inc.; Atty. Bridget Rose M. Mesina-Romero, Director, Payments Policy and Development

Global Tech Sales Forecast to Reach $1.4 Trillion in 2026, Even as 56% of Consumers Delay Purchases, NIQ Finds1.9.2026 09:00:00 CEST | Press release

Global study finds price-sensitive shoppers will still pay more when products deliver clear, lasting benefits Global sales of consumer technology and durable goods are forecast to reach $1.4 trillion in 2026, up 5.1% year over year, even as 56% of consumers say they have delayed a technology purchase because of price or while waiting for a discount, according to new research from NIQ (NYSE: NIQ), the Official Global Insights Partner of IFA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901758503/en/ The era of automatic tech & durables upgrades is over. Released ahead of IFA 2026, which kicks off in Berlin on Sept. 4, 2026, NIQ today released its annual “State of Tech & Durables” report. Consumer Tech Trends 2027: How to Win When Every Purchase Must Be Justified examines how years of economic volatility have transformed technology purchasing behavior and what manufacturers and retailers must do to remain competitive. Key

Searchlight Capital Partners Announces Investment in Aderian Group1.9.2026 09:00:00 CEST | Press release

Partnership will support Aderian’s continued growth and expansion across the Nordic region Searchlight Capital Partners, L.P. ("Searchlight"), a leading global private investment firm, today announced an investment in Aderian Group ("Aderian" or the "Company"), a Nordic managed IT services provider serving more than 10,000 small and medium-sized enterprise ("SME") customers throughout Sweden and Norway. As part of the transaction, Aderian's management team will reinvest in the Company and remain meaningful shareholders alongside Searchlight, underscoring their continued commitment to Aderian's long-term growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260901430715/en/ Aderian provides cloud, cybersecurity, AI and analytics, networking and modern workplace solutions. Since its founding in 2022, the Company has grown to approximately SEK 2.5 billion in revenue, with more than 850 employees and over 10,000 SME customers a

FluoSphera Licenses Debiopharm’s AbYlink™ Technology for 3D Antibody Characterization while Leveraging Leica Microsystems Viventis Deep Imaging Capabilities1.9.2026 09:00:00 CEST | Press release

New license agreement enables an integrated workflow combining antibody labeling, human-relevant 3D testing and quantitative imaging for antibody-based therapeutics Debiopharm (Debiopharm Research & Manufacturing), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases and FluoSphera, a Swiss biotechnology company developing advanced in vitro platforms to improve the prediction of drug efficacy and safety, today announced a new license agreement for use of AbYlink™, Debiopharm’s proprietary antibody conjugation technology. The agreement enables FluoSphera to offer biotechnology and pharmaceutical companies an integrated workflow combining regio-selective antibody labeling, high-throughput testing in human-relevant three-dimensional models and quantitative imaging analysis. The new offering is designed to support the characterization of antibody-drug conjugates (ADCs), bispecific antibodies, therape

Enhertu® Plus Pertuzumab Approved in the EU as First New Regimen in More than a Decade for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer1.9.2026 08:30:00 CEST | Press release

Approval based on DESTINY-Breast09 phase 3 trial results that showed Daiichi Sankyo and AstraZeneca’s Enhertu plus pertuzumab reduced the risk of disease progression or death by 44% versus THP with a median progression-free survival exceeding three years Second approval for Enhertu in the EU in two months Enhertu® (trastuzumab deruxtecan) in combination with pertuzumab has been approved in the European Union (EU) for the first-line treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results fro

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye